Healius Limited (ASX:HLS)
0.5100
-0.0100 (-1.92%)
Apr 7, 2026, 4:10 PM AEST
Healius Market Cap
Healius has a market cap or net worth of 370.33 million as of April 7, 2026. Its market cap has decreased by -61.94% in one year.
Market Cap
370.33M
Enterprise Value
1.26B
Revenue
1.37B
Ranking
n/a
PE Ratio
n/a
Stock Price
0.51
Market Cap Chart
Since August 29, 2000, Healius's market cap has decreased from 478.57M to 370.33M, a decrease of -22.62%. That is a compound annual growth rate of -1.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 370.33M | -43.65% |
| Dec 31, 2025 | 657.15M | -33.94% |
| Dec 31, 2024 | 994.80M | -16.20% |
| Dec 29, 2023 | 1.19B | -32.22% |
| Dec 30, 2022 | 1.75B | -43.13% |
| Dec 31, 2021 | 3.08B | 32.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sonic Healthcare | 9.87B |
| Integral Diagnostics | 837.78M |
| Australian Clinical Labs | 380.63M |
| Monash IVF Group | 257.16M |
| Rhythm Biosciences | 63.66M |
| Cryosite | 53.45M |
| INOVIQ | 48.57M |
| Microba Life Sciences | 41.41M |